The study of dauer formation in C. elegans has been instrumental in our understanding of both the insulin and TGFB signaling pathways. It is my intent to use C. elegans to identify neuronal signaling molecules involved in the regulation of these neuroendocrine outputs. Preliminary experiments have identified cyclic GMP and cyclic GMP regulated ion channels as being important for regulation of dauer formation. Here I present additional genetic and genomic experiments which aim to uncover the mechanism(s) of cGMP and CNG channel regulation of neuroendocrine outputs in the genetic model organism C. elegans. Given the prominent role that ion-channels play in signal processing it is not surprising that many inherited human diseases are the results of mutations in channel genes (channelopathies). It is my hope that these studies will unveil the identity and function of additional evolutionarily conserved neuronal signaling molecules that may increase our understanding of the pathologies of these diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Postdoctoral Individual National Research Service Award (F32)
Project #
5F32NS041734-03
Application #
6639788
Study Section
Special Emphasis Panel (ZRG1-MDCN-1 (01))
Program Officer
Mitler, Merrill
Project Start
2002-05-01
Project End
Budget Start
2003-05-01
Budget End
2004-04-30
Support Year
3
Fiscal Year
2003
Total Cost
$49,864
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199